Eyegate Pharmaceuticals, Inc.
Records under this name other than patents Eyegate Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Eyegate Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,376,214 | Compositions and Methods for Treatment of Ocular Diseases Formerly held Lapsed on the fee record Ended Jul 5, 2026 · High confidence | Lapsed on the fee record | Ended Jul 5, 2026 | High confidence |
| US 9,937,074 | Iontophoretic contact lens Lapsed on the fee record Ended Apr 10, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 10, 2026 | USPTO record |
| US 9,149,525 | Delivery of corticosteroids through iontophoresis Lapsed on the fee record Ended Oct 6, 2023 · USPTO record | Lapsed on the fee record | Ended Oct 6, 2023 | USPTO record |
| US 10,376,463 | Ocular iontophoretic delivery of dexamethasone and formulations thereof Lapsed on the fee record Ended Aug 13, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 13, 2023 | USPTO record |
| US 9,820,935 | Delivery of corticosteroids through iontophoresis Lapsed on the fee record Ended Nov 21, 2021 · USPTO record | Lapsed on the fee record | Ended Nov 21, 2021 | USPTO record |
| US 9,539,141 | System and method for ocular iontophoresis with buffering Lapsed on the fee record Ended Jan 10, 2021 · USPTO record | Lapsed on the fee record | Ended Jan 10, 2021 | USPTO record |
| US 9,180,292 | System and method for ocular iontophoresis with buffering Lapsed on the fee record Ended Nov 10, 2019 · USPTO record | Lapsed on the fee record | Ended Nov 10, 2019 | USPTO record |